Laura Valle, PhD, is a Principal Investigator at the Catalan Institute of Oncology, IDIBELL. The research of her group is focused on the identification of the genetic causes of colorectal cancer predisposition, and the better characterization of new hereditary colorectal cancer and polyposis syndromes. She has contributed to the clinical and molecular characterization of the polymerase proofreading-associated polyposis, caused by germline pathogenic variants in the exonuclease domains of POLE and POLD1; the NTHL1 tumor syndrome; and the RNF43-associated serrated polyposis. Dr. Valle carried out her PhD on hereditary nonpolyposis colorectal cancer at the Spanish Cancer Research Center (CNIO), after which she moved to Ohio State University as postdoctoral researcher under the supervision of Dr. Albert de la Chapelle. Since 2009 she leads her own research group, part of the Hereditary Cancer Group of IDIBELL. She received in 2012 the National award to the most outstanding young researcher in Human Genetics; in 2013, the l’Oréal-UNESCO “for women in science” research award; and in 2020, the Best Female Researcher recognition awarded by the National collaborative network on cancer research (CIBERONC).